Radiation-induced lung injury (RILI) is a form of radiation damage to normal lung tissue
caused by radiotherapy (RT) for thoracic cancers, which is most commonly comprised of …

Radiation pneumonitis (RP) and radiation fibrosis (RF) are two dose-limiting toxicities of
radiotherapy (RT), especially for lung, and esophageal cancer. It occurs in 5–20% of …

Radiation-induced lung injury (RILI) is one of the main dose-limiting side effects in patients
with thoracic cancer during radiotherapy. No reliable predictors or accurate risk models are …

Methods PubMed was used to collect articles about RILI from 1995 to 2021. The papers
included clinical trials, reviews, as well as systematic reviews and meta-analyses. Based on …

Radiotherapy is a prevalent treatment modality for thoracic tumors; however, it can lead to
radiation-induced lung injury (RILI), which currently lacks effective interventions. ACT001, a …

Radiation-induced lung injury (RILI) remains a major obstacle for thoracic radiotherapy for
the treatment of lung cancer, esophageal cancer and lymphoma. It is the principal dose …

Lung, breast, and esophageal cancer represent three common malignancies with high
incidence and mortality worldwide. The management of these tumors critically relies on …

Cancer research has advanced throughout the years with respect to the personalization of
the treatments and to targeting cancer-related molecular signatures on different organs. Still …

Acute lung injury (ALI), a critical respiratory disorder that causes diffuse alveolar injury leads
to high mortality rates with no effective treatment. ALI is characterized by varying degrees of …

Background Pneumonitis is a potential consequence of both lung-directed radiation and
immune checkpoint blockade (ICB), particularly treatment with PD-1/PD-L1 inhibitors …